COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation

Complications resulting from coronavirus disease 2019 (COVID-19) sequelae have been well documented. These include blood conditions such as lymphopenia, thrombocytopenia, and hypercoagulability. Less common problems that may arise are disseminated intravascular coagulation (DIC), immune thrombocytop...

Descripción completa

Detalles Bibliográficos
Autores principales: Dube, Michael D, Sapkota, Sumina, Lakhatariya, Khushboo, Russo, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867565/
https://www.ncbi.nlm.nih.gov/pubmed/36694508
http://dx.doi.org/10.7759/cureus.32845
Descripción
Sumario:Complications resulting from coronavirus disease 2019 (COVID-19) sequelae have been well documented. These include blood conditions such as lymphopenia, thrombocytopenia, and hypercoagulability. Less common problems that may arise are disseminated intravascular coagulation (DIC), immune thrombocytopenic purpura (ITP), and pancytopenia. Furthermore, the majority of COVID-19 patients to develop pancytopenia have been immunosuppressed. We present a case of a previously immunocompetent patient who subsequently developed pancytopenia, DIC, as well as symptoms of ITP one month after being diagnosed with COVID-19.

Ejemplares similares